My PCR
Create Account
Logo PCR

22 May 2025

Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?

With the collaboration of the Israel's Interventional Cardiology Working Group and Swedish Working Group on Percutaneous Coronary and Valvular Interventions

Anchorpersons: R. Linder, S. Minha
Discussants: S. Völz, Y. Szekely
SHOW MORE

Summary

Explore the evolving landscape of catheter-directed therapy for intermediate-high and high-risk pulmonary embolism. This session covers patient selection criteria, clinical signs indicating the need for intervention, management of potential complications, and ongoing studies shaping future treatments. Case-based discussions illustrate practical applications and key learnings.

Learning Objectives

  • To explore the percutaneous catheter-directed therapy solutions available for pulmonary embolism in 2025 and determine the best choice for each individual patient
  • To identify key clinical signs in an intermediate high-risk pulmonary embolism patient when considering catheter-directed therapy
  • To address the management of potential complications related to catheter-directed therapy in pulmonary embolism
  • To review ongoing studies that will provide further insights into catheter-directed therapy for pulmonary embolism

Presentations available when logged in:

  • Case 1 - The perfect storm
  • How would I treat case 1?
  • Case 1 treatment
  • Case 2 - Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism. Where do we stand?
  • How would I treat case 2?
  • Case 2 treatment
  • Key learnings Case 2
  • Session evaluation and key learnings